Swapnroop Drugs & Pharmaceuticals is a Relatlimab API manufacturer, supplier, and exporter in India, offering Relatlimab biologic active pharmaceutical ingredient sourcing and supply support for biopharmaceutical research, oncology development, analytical requirements, formulation development, and international pharmaceutical projects.
Relatlimab is a human IgG4 monoclonal antibody targeting lymphocyte activation gene-3, commonly known as LAG-3 or CD223. It is associated with immune checkpoint inhibition and immuno-oncology pharmaceutical applications.
We focus on consistent product quality, controlled sourcing, batch-to-batch reliability, appropriate biologic handling, and comprehensive technical documentation. Relatlimab API requirements can be supported according to customer-specific quality parameters and applicable biopharmaceutical specifications.
We support Relatlimab API and biologic active substance requirements for biopharmaceutical companies, oncology pharmaceutical organizations, biotechnology companies, contract research organizations, research institutions, pharmaceutical distributors, and authorized international buyers.
Our Relatlimab API supply services support:
Relatlimab API is evaluated according to applicable biologic quality parameters, analytical methods, product specifications, and customer requirements.
Typical Quality Parameters Include:
Appearance: Clear to slightly opalescent solution or as per specification
Identification: Complies with specification
Protein Concentration: As per approved specification
Purity: As per specification
Purity by SEC-HPLC: As per approved specification
Charge Variants: Within specified limits
High Molecular Weight Species: Within specified limits
Low Molecular Weight Species: Within specified limits
Binding Activity: As per validated biological assay
Biological Activity / Potency: As per approved specification
LAG-3 Binding Activity: As per specification
LAG-3 Blocking Activity: As per validated biological assay
pH: As per approved specification
Endotoxin: Within specified limits
Bioburden: As applicable
Sterility: As applicable
Host Cell Protein: Within specified limits
Residual Host Cell DNA: Within specified limits
Residual Protein A: Within specified limits, as applicable
Particulate Matter: As per applicable requirements
Actual specifications may vary depending on manufacturing process, expression system, purification process, formulation, analytical methods, intended use, development stage, regulatory requirements, and customer-approved specifications.
Relatlimab API is associated with the biopharmaceutical industry as a monoclonal antibody active substance targeting the LAG-3 immune checkpoint receptor.
Relatlimab is a LAG-3 blocking antibody associated with immuno-oncology pharmaceutical development and immune checkpoint inhibitor therapeutic applications.
Its biological activity is associated with binding to LAG-3 and blocking LAG-3-mediated inhibitory signaling. Inhibition of the LAG-3 pathway can support T-cell activation and immune responses against tumor cells.
Relatlimab is associated with oncology therapeutic applications involving immune checkpoint blockade and has been developed in combination with PD-1 pathway inhibition for certain melanoma-related therapeutic applications, subject to applicable regulatory approvals and prescribing requirements.
Relatlimab API is primarily intended for use by licensed biopharmaceutical manufacturers, biotechnology organizations, oncology pharmaceutical companies, research institutions, contract research organizations, and authorized pharmaceutical organizations.
Swapnroop Drugs & Pharmaceuticals offers reliable Relatlimab API sourcing and supply support for domestic and international biopharmaceutical requirements.
Our Key Advantages:
We support the export and international supply coordination of Relatlimab API and biologic pharmaceutical materials from India to pharmaceutical companies, biotechnology organizations, oncology research institutions, distributors, and authorized buyers across international markets.
Export documentation and product information can be provided based on destination-country requirements, customer specifications, intended use, cold-chain requirements, and applicable regulatory procedures.
We serve pharmaceutical and biopharmaceutical buyers across Asia, Africa, the Middle East, Latin America, and other international pharmaceutical markets.
Looking for a reliable Relatlimab API manufacturer in India, Relatlimab API supplier in India, or Relatlimab API exporter from India?
Contact Swapnroop Drugs & Pharmaceuticals for Relatlimab API requirements, technical documentation, COA, SDS, pricing, packaging details, biologic handling information, and export inquiries.
Company: Swapnroop Drugs & Pharmaceuticals
Product: Relatlimab API
CAS Number: 1673516-98-7
Supply Type: Biologic API / Monoclonal Antibody Active Substance
Country of Origin: India
Email: enquiry@sdp.org.in